Document Detail

Inhibition of mitochondrial respiration by furancarboxylic acid accumulated in uremic serum in its albumin-bound and non-dialyzable form.
MedLine Citation:
PMID:  8448924     Owner:  NLM     Status:  MEDLINE    
3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF) accumulates markedly in uremic serum in its albumin-bound form. To determine if CMPF can be removed by newly developed dialyzers with high-flux membranes which are permeable to low-molecular-weight proteins, such as beta 2-microglobulin (beta 2-MG), serum levels of CMPF were determined before and after hemodialysis using these high-flux membrane dialyzers. In addition, to determine the pathogenic role of CMPF in uremic patients, its cellular toxicity due to its effect on mitochondrial respiration was studied. The reduction rates of CMPF by hemodialysis using the dialyzers ranged from -17% to -24%, demonstrating the nondialyzability of CMPF due to its strong albumin-binding, while those of beta 2-MG ranged from 11% to 43%. CMPF inhibited ADP-stimulated oxidation of NADH-linked substrates in isolated mitochondria dose-dependently regardless of the presence of serum albumin. This inhibition was observed even at a concentration of 0.2 mM, which is comparable to the serum levels of CMPF in the hemodialysis patients. In conclusion CMPF which cannot be removed even by high-flux membrane dialyzers, is a strong inhibitor of mitochondrial respiration, and novel purification methods to remove CMPF from the blood of uremic patients should be developed.
T Niwa; T Aiuchi; K Nakaya; Y Emoto; T Miyazaki; K Maeda
Related Documents :
19521094 - Mrna of placental origin in maternal serum of women with normal and preeclamptic pregna...
21381594 - Successful pregnancy outcome after fertility-sparing surgery and chemotherapy for dysge...
19346754 - Placental growth factor: a predictive marker for preeclampsia?
15952984 - Inhibin a is a maternal serum marker for down's syndrome early in the first trimester.
12001204 - Factors affecting outcomes of prenatally-diagnosed tumours.
12962264 - Fetal and maternal plasma leptin levels during the second half of normal pregnancies an...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Clinical nephrology     Volume:  39     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  1993 Feb 
Date Detail:
Created Date:  1993-04-09     Completed Date:  1993-04-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  92-6     Citation Subset:  IM    
Department of Internal Medicine, Nagoya University Branch Hospital, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Furans / blood*,  pharmacology
Kidney, Artificial*
Membranes, Artificial*
Mitochondria, Liver / metabolism*
Oxygen Consumption / drug effects*
Propionic Acids / blood*,  pharmacology
Renal Dialysis
Serum Albumin / metabolism
Uremia / blood*,  therapy
Reg. No./Substance:
0/Furans; 0/Membranes, Artificial; 0/Propionic Acids; 0/Serum Albumin; 86879-39-2/3-carboxy-4-methyl-5-propyl-2-furanpropionic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effect of pilocarpine on electrodermal resistance in chronic hemodialyzed patients.
Next Document:  Effects of erythropoietin on strength and functional status of patients on hemodialysis.